DETECT Health Study

Volunteer to use your wearable device to help @ScrippsDTC scientists spot viral outbreaks. Join #DETECTSTUDY.

[DETECT Health Study @detect_study]

New data from our scientists published in @LancetDigitalH shows how #wearable sensors can provide real-time COVID-19 tracking and forecasting. ⌚️

https://t.co/arubKW3Nkr

[Scripps Research Digital Trials Center @ScrippsDTC]

Stuck at home with COVID-19? If you tested positive within the last 48 hours and are in the United States, you may be eligible to join the @scrippsresearch-@eMedCertified COVID Monitoring Study and may earn compensation for your contribution!

https://t.co/rfA4ukOCZ5

[Cue Health @CueHealth]

If you're immunocompromised or age 65+, please consider joining the @ScrippsDTC ImmunoCARE study.

Participants will receive free molecular COVID-19 tests, as well as telemedicine, and rapid home delivery of medication, if prescribed.

Learn more: https://t.co/1nLKSg8JvR

[Scripps Research Digital Trials Center @ScrippsDTC]

Positive COVID-19 test in the last 48 hours? Join Scripps-eMed COVID Monitoring Study and make a difference! Short surveys, rapid tests, and compensation for your contribution.

Learn more: https://t.co/ZVw2b74JNj

[Scripps Research Digital Trials Center @ScrippsDTC]

Did you test positive for COVID-19 within the last 48 hours? Do you live in the United States? You may be eligible to join the free, home-based @scrippsresearch -@eMedCertified COVID Monitoring Study.

https://t.co/2soPL09H7C

[Scripps Research Digital Trials Center @ScrippsDTC]

Make a difference in the fight against COVID-19! If you've tested positive within the last 48 hours, you may be eligible to participate. As a participant, you will be asked to complete short surveys, rapid tests, and provide small blood samples.

https://t.co/ziBo5JZaAP

[Scripps Research Digital Trials Center @ScrippsDTC]

As our thanks for your participation in ImmunoCARE, a collaboration between us & @CueHealth, all eligible participants will receive a series of Amazon gift cards as compensation for time throughout the study.

Learn more: https://t.co/DYg0zTHfcc

[Cue Health @CueHealth]

We're excited to partner with @ScrippsDTC on the ImmunoCARE study, which provides free molecular COVID-19 tests, telemedicine, and rapid home delivery of medication, if prescribed.

If you're immunocompromised or age 65+, please consider joining: https://t.co/NpHIn3Xkpa

[Eric Topol @EricTopol]

If you are immunocompromised or age 65+, please consider joining our study that provides free molecular Covid tests, telemedicine, and rapid Paxlovid home delivery. ⁦@ScrippsRTI⁩ ⁦@scrippsresearch⁩ ⁦@CueHealth⁩ ⁦@julialmv⁩ https://t.co/Szw2SHM5k7

[Scripps Research Digital Trials Center @ScrippsDTC]

Did you test positive for COVID-19 within the past 2 days? Find out if you qualify to join the free, home-based study led by @scrippsresearch & @eMedCertified. Compensation may be available. (US residents only)

To learn more, visit: https://t.co/BApdTGW7Rx

[Scripps Research Digital Trials Center @ScrippsDTC]

Did you test positive for COVID-19 within the past 2 days? You may be eligible to participate in a free, home-based study led by @scrippsresearch & @eMedCertified.

Discover more about this exciting research opportunity and how you can contribute!

https://t.co/djGeM12HiL

[Scripps Research Digital Trials Center @ScrippsDTC]

An example of how wearables can give a more complete picture of someone’s health is conditions like #longcovid.

Learn more from @julialmv in this @scrippsresearch short:

[Scripps Research Digital Trials Center @ScrippsDTC]

We partnered with @CueHealth on ImmunoCARE, a research project aiming to reduce hospitalizations & deaths from COVID-19 infections among those who are at high risk of adverse outcomes.

https://t.co/Pz8HtvebfR

[Scripps Research Digital Trials Center @ScrippsDTC]

Have you tested positive for COVID-19 in the past 48 hours? You can make a difference! As a participant, you will complete short surveys, rapid tests, and provide small blood sample, and may also earn compensation.

Learn more: https://t.co/7HhtLz6fBs

[Scripps Research Digital Trials Center @ScrippsDTC]

Did you test positive for COVID-19 within the last 48 hours? Do you live in the United States? You may be eligible to join the free, home-based Scripps-eMed COVID Monitoring Study.

https://t.co/2soPL09H7C

[Scripps Research Digital Trials Center @ScrippsDTC]

Did you test positive for COVID19 within the past 2 days? Find out if you qualify to join the free, home-based Scripps-eMed COVID Monitoring Study!

Compensation may be available. Learn more here: https://t.co/BApdTGVA1Z

[Michael Mina @michaelmina_lab]

If you've Tested positive for COVID-19 in the past 48 hours:

You may be eligible to participate in an at-home study. As a participant, you'll complete short surveys, rapid tests, & provide small blood sample, and may also earn compensation. Learn more:

https://t.co/U3e50EkvuZ

[Michael Mina @michaelmina_lab]

To clarify other points, the study is *entirely at home*

No driving

The study will ship your study kit w all that you need to participate

Even the home blood collection is a super simple at home collection called Tasso. It's a cool device, IMO

See picture here:

[Michael Mina @michaelmina_lab]

We are studying COVID rebound, including Paxlovid rebound.

If you have tested positive within the past 2 days, please take a look below.

A Fully at-home study that sends everything to your house and compensates for your time/energy/participation

[Scripps Research Digital Trials Center @ScrippsDTC]

Make a difference in the fight against COVID-19! If you've tested positive within the last 48 hours, you may be eligible to participate. As a participant, you will be asked to complete short surveys, rapid tests, and provide small blood samples.

https://t.co/ziBo5JYCLh

[Scripps Research Digital Trials Center @ScrippsDTC]

We partnered with @CueHealth on ImmunoCARE, a research project aiming to reduce hospitalizations & deaths from COVID-19 infections among those who are at high risk of adverse outcomes.

Learn more in this short video:
https://t.co/L0LIz8drTE